Valiant Laboratories Limited is an India-based pharmaceutical ingredient manufacturing company. The Company is focused on manufacturing a Paracetamol active pharmaceutical ingredient (API)/bulk drug. It has several applications in the treatment of conditions such as headache, muscle ache, arthritis, backache, toothache, cold and fever. It is also used in the management of severe pain such as post-surgical and cancer pain. It operates a single-location manufacturing facility on the Tarapur industrial estate.

Employees

Sector

Specialty Chemicals

More about the company

Quotes

Date	Price	Change	Volume
26-10-09	₹119.80	+2.10%	57,995
26-10-08	₹117.34	-4.76%	67,041
26-10-07	₹123.21	-0.93%	45,361
26-10-06	₹124.37	-0.17%	73,168
26-10-05	₹124.58	-0.40%	70,647

End-of-day quote NSE India S.E.

More quotes

End-of-day quote NSE India S.E. 2026-10-09			5-day change	1st Jan Change
119.80 ^INR	+2.10%		-4.22%	+71.14%

10-05	8,694,345 Equity Shares of Valiant Laboratories Limited are subject to a Lock-Up Agreement Ending on 6-OCT-2026.	CI
09-29	Valiant Laboratories Limited Announces Change in Registered Office Address	CI

Market Cap	6.51B 67.23M 60.04M 55.86M 50.81M 95.93M 96.34M 672M 263M 3.32B 252M 247M 10.65B	P/E 2025	-150x	P/E 2026	-79.4x
Enterprise Value	6.64B 68.58M 61.25M 56.98M 51.83M 97.85M 98.28M 686M 269M 3.38B 258M 252M 10.86B	EV / Sales 2025	2.83x	EV / Sales 2026	1.24x
Free-Float	23.22%	Yield 2025 *	-	Yield 2026	-

Markets		Quality
NSE India S.E.	VALIANTLAB	End-of-day quote
Bombay S.E.	VALIANTLAB	Delayed

10-05	8,694,345 Equity Shares of Valiant Laboratories Limited are subject to a Lock-Up Agreement Ending on 6-OCT-2026.	CI
09-29	Valiant Laboratories Limited Announces Change in Registered Office Address	CI
08-10	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-10	Valiant Laboratories Limited Approves the Opening of New Corporate Office	CI
05-20	Valiant Organics Limited agreed to acquire 34.26% stake in Valiant Laboratories Limited from Dhanvallabh Ventures LLP.	CI
05-14	Valiant Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
04-23	Valiant Laboratories Limited Announces Resignation of Bhanudas D. Patil as Q.C Manager, Senior Management Personnel, Effective April 22, 2026	CI
02-11	Valiant Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
01-15	Valiant Laboratories Ltd receives notice for total tax demand of approx. 125.3 million rupees	RE
11-11	Valiant Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
11-07	Valiant Laboratories Arm Begins Commercial Operations at New Unit in Gujarat, India; Shares Up 4%	MT
25-09-25	Valiant Laboratories Limited Approves Change in Designation of Paresh Shah from Executive Director to Whole-Time Director, Effective September 25, 2025	CI
25-08-08	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI

Valiant Laboratories Limited Stock

Stocks

VALIANTLAB

INE0JWS01017

Specialty Chemicals

Valuation: Valiant Laboratories Limited

Chart: Valiant Laboratories Limited

Latest news: Valiant Laboratories Limited

Quotes and Performance

Price Extremes

Managers and Directors: Valiant Laboratories Limited

Other Specialty Chemicals

Financials

Company Profile

Quotes

1 day	+2.10%
1 week	-4.22%
Current month	-5.09%
1 month	-0.03%
3 months	+92.73%
6 months	+107.59%
Current year	+71.14%

1 week	113	128.85
1 month	111.25	132.25
Current year	49.51	132.25
1 year	49.51	132.25
3 years	49.51	214.95
5 years	49.51	214.95
10 years	49.51	214.95

Manager	Title	Age	Since
Santosh Vora CEO	Chief Executive Officer	32	2021-08-20
Paresh Shah DFI	Director of Finance/CFO	66	2021-08-15
Akshay Dnyaneshwar Gangurde CMP	Compliance Officer	-	2025-07-08

Director	Title	Age	Since
Santosh Vora BRD	Director/Board Member	32	2021-08-20
Sonal Amit Vira BRD	Director/Board Member	44	2022-02-15
Paresh Shah BRD	Director/Board Member	66	2021-08-15

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VALIANT LABORATORIES LIMITED	+2.10%	-4.22%	+35.51%	-28.50%	67.23M
ECOLAB INC.	+0.05%	+2.97%	+3.41%	+68.08%	79.01B
GIVAUDAN SA	+0.91%	+2.38%	+1.87%	+21.64%	38.22B
SIKA AG	+1.73%	-5.44%	+0.32%	-23.94%	33.56B
HENKEL AG & CO. KGAA	+0.84%	+2.99%	+6.01%	+9.18%	31.96B
NOVONESIS A/S	+1.68%	+4.59%	+7.88%	+49.83%	30.37B
FUJIFILM HOLDINGS CORPORATION	+0.32%	+3.41%	-7.50%	+20.53%	25.88B
EMS-CHEMIE HOLDING AG	+2.24%	+4.08%	+54.41%	+41.78%	24.41B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-0.95%	-0.95%	+47.87%	+20.49%	18.26B
DUPONT DE NEMOURS, INC.	-1.87%	+0.02%	-44.33%	-42.43%	17.56B
Average	+0.71%	+1.18%	+10.54%	+13.67%	29.93B
Weighted average by Cap.	+0.63%	+1.93%	+6.73%	+28.02%

	2025	2026
Net sales	1.33B 13.78M 12.31M 11.45M 10.41M 19.66M 19.75M 138M 54M 680M 51.75M 50.62M 2.18B	2.37B 24.54M 21.91M 20.39M 18.54M 35.01M 35.16M 245M 96.13M 1.21B 92.14M 90.13M 3.89B
Net income	-22.01M -227K -203K -189K -172K -325K -326K -2.27M -891K -11.22M -854K -835K -36.01M	-32.68M -338K -302K -281K -255K -482K -484K -3.38M -1.32M -16.66M -1.27M -1.24M -53.47M
Net Debt	453M 4.68M 4.18M 3.89M 3.54M 6.68M 6.71M 46.79M 18.33M 231M 17.57M 17.19M 741M	131M 1.35M 1.21M 1.12M 1.02M 1.93M 1.93M 13.5M 5.29M 66.6M 5.07M 4.96M 214M